1[1]vander Krol AR,Mur LA,de Lange P,et al.Inhibition of flower pigmentation by antisense CHS genes:promoter and minimal sequence requirements for the antisense effect[J].Plant Mol Biol,1990,14 (4):457-466.
2[2]Guo S,Kemphues KJ.Par-1,a gene required for establishing polarity in C.elegans embryos,encodes a putative Ser/Thr kinase that is asymmetrically distributed[J].Cell,1995,81 (4):611-620.
5[5]Carmell MA,Xuan Z,Zhang MQ,et al.The Argonaute family:tentacles that reach into RNAi,developmental control,stem cell maintenance,and tumorigenesis[J],Genes Dev,2002,16(21):2733-2742.
6[6]Sijen T,Fleenor J,Simmer F,et al.On the role of RNA amplification in dsRNA triggered gene silencing[J].Cell,2001,107(4):465-476.
7[7]Lipardi C,Wei Q,Paterson BM.RNAi as random degradative PCR:siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs[J].Cell,2001,107 (3):297-307.
8[8]Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of nucleotide RNAs mediate RNA interference in cultured mammalian cells[J].Nature,2001,411 (6836):494-498.
9[9]Caplen NJ,Parrish S,Imani F,et al.Specific inhibition of gene expression by small double stranded RNAs in invertebrate and vertebrate systems[J].Proc Natl Acad Sci USA,2001,98(17):9742-9747.
10[10]Vickers TA,Koo S,Bennett CF,et al.Efficient reduction of target RNAs by small interfering RNA and RNase H2 dependent antisense agents.A comparative analysis[J].J Biol Chem,2003,278 (9):7108-7118.
2Wilda M,Fuchs U,Wossmann W,et al.Killing of leukemic cells with a BCR ABL fusion gene by RNA interference (RNAi)[].Oncegene.2002
3Cioca DP,Aoki Y,Kiyosawa K.RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines[].Cancer Gene Therapy.2003
4McCaffrey AP,Meuse L,Pham TTT,et al.RNA interference in adult mice[].Nature.2002
5Elbashir SM,Harborth J,Weber K,et al.Analysis of gene function in somatic mammalian cells using small interfering RNAs[].Methods.2002
6Heidenreich O,Krauter J,Riehle H,et al.AML1 MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells[].Blood.2003
7Lewis DL,Hagstrom JE,Loomis AG,et al.Efficient delivery of siRNA for inhibition of gene expression in postnatal mice[].Nature Genetics.2002
8Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[].Nature.2001
9Scherr M,Battmer K,Winkler T,et al.Specific inhibition of bcr-abl gene expression by small interfering RNA[].Blood.2003
1Lage H. An overview of cancer multidrug resistance: a still unsolved problem. Cell Mol Life Sci, 2008,65(20) :3145-3167.
2Kuo MT. Redox regulation of muhidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal, 2009,11 ( 1 ) :99-133.
3Montecucco A, Biamonti G. Cellular response to etoposide treatment. Cancer Lett, 2007,252( 1 ) :9-18.
4Townsend DM ,Tew KD. The role of glutathione-S-transferase in anticancer drug resistance. Oncogene,2003,22(47 ) :7369-7375.
5Tuschl T. Functional genomics : RNA sets the standard. Nature, 2003, 421 (6920) :220-222.
6Rothenberg SM, Engelman JA, Le S, et al. Modeling oncogene addiction using RNA interference. Proc Natl Acad Sci USA,2008, 105(34):12480-12484.
7Pop I, Pop L, Vitetta ES, et al. Generation of multidrug resistant lymphoma cell lines stably expressing P-glycoprotein. Oncol Rep, 2008,19(4) :889-895.
8Jin W, Scotto KW, Halt WN, et al. Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells. Biochem Pharmacol,2007,74 ( 6 ) : 851 - 859.
9Stein U, Walther W, Stege A, et al. Complete in vivo reversal of the multidrug resistance phenotype by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA. Mol Ther,2008,16 ( 1 ) : 178- 186.
10Congmin G, Mu Z, Yihui M, et al. Survivin-an attractive target for RNAi in non-Hodgkin' s lymphoma, Daudi cell line as a model. Leuk Lymphoma,2006,47 ( 9 ) : 1941 - 1948.
